Vincent Figueredo is a Cardiology physician. OpenAlex indexes 290 publications with 6,627 citations (h-index 43).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1203 Langhorne Newtown Rd Ste 320
Langhorne, PA 19047
Telephone
215-750-7818Provider last certified this registry record 11 May 2021.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20257 payments
- E.R. Squibb & Sons, L.L.C.Program year202511 payments
- Alnylam Pharmaceuticals Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.4%Statin18.2%Atorvastatin Calcium63%Rosuvastatin Calcium32%Pravastatin Sodium3%Simvastatin2%Part D<11 patientsBeta blocker16.9%Metoprolol Succinate64%Carvedilol13%Metoprolol Tartrate10%Labetalol Hcl6%Sotalol4%Atenolol3%Part D<11 patients+ 15 more classes in this area
Blood & clotting
10.8%Factor Xa inhibitor7.5%Eliquis93%Xarelto7%Part D<11 patientsP2Y12 inhibitor2.9%Clopidogrel82%Brilinta18%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.8%SGLT2 inhibitor0.9%Farxiga100%Part D<11 patientsPotassium supplement0.9%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography)
Journal of the American College of Cardiology
2019 - Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension
International Journal of Cardiology
2019 - Takotsubo syndrome: State-of-the-art review by an expert panel – Part 1
Cardiovascular revascularization medicine
2018 - Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample
Journal of Cardiovascular Medicine
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”